Search

Your search keyword '"Hyun Moo Lee"' showing total 415 results

Search Constraints

Start Over You searched for: Author "Hyun Moo Lee" Remove constraint Author: "Hyun Moo Lee"
415 results on '"Hyun Moo Lee"'

Search Results

101. Comparison of Biopsy Results and Surgical Outcomes of Magnetic Resonance Imaging-Guided and Transrectal Ultrasonography-Guided Repeat Biopsy

102. Role of Magnetic Resonance Imaging Using Prostate Imaging-Reporting and Data System Version 2 to Predict Clinically Significant Cancer After Radical Prostatectomy in Very Low-Risk or Low-Risk Prostate Cancer

103. Incidence of Pathological Downgrading and Treatment Outcome After Radical Prostatectomy in Patients With Biopsy Confirmed High Gleason Score Prostate Cancer

104. Comparison of Oncologic Outcomes and Complications According to Surgical Approach to Radical Prostatectomy: Special Focus on the Perineal Approach

105. Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry

107. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4 cm)? A propensity score–matched study

108. Formation of glycine from HCN and H2O: A computational mechanistic study

109. Postoperative Outcome of Cystic Renal Cell Carcinoma Defined on Preoperative Imaging: A Retrospective Study

110. Re-stratification of Patients with High-Risk Prostate Cancer According to the NCCN Guidelines among Patients Who Underwent Radical Prostatectomy: An Analysis Based on the K-CaP Registry

111. Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)

112. Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors

113. Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma

114. MP31-17 COMPARISON OF RETROPERITONEAL AND TRANSPERITONEAL ROBOTIC PARTIAL NEPHRECTOMY BY PENTAFECTA PERIOPERATIVE AND RENAL FUNCTIONAL OUTCOMES

115. Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors

116. Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma.

117. Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients

118. Comparisons between Standard and Extended Pelvic Lymph Node Dissections During Radical Cystectomy in Patients with Bladder Cancer: Emphasis on Staging Ability and Perioperative Complications

119. Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer

120. Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy

121. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2

122. Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion

123. The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients

124. Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma

125. Comparison of preoperative adaptive enlargement of the contralateral normal kidney in patients nephrectomized for benign non-functioning kidney versus renal cell carcinoma

126. Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results

127. Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma

128. Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance

129. Phase II study of biweekly docetaxel plus androgen-deprivation therapy (ADT) in patients with previously-untreated, metastatic, prostatic adenocarcinoma

130. Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma

131. Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy

132. MP68-01 PREOPERATIVE VS POSTOPERATIVE COMPENSATION OF THE CONTRALATERAL NORMAL KIDNEY IN PATIENTS TREATED WITH RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA

133. Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion

134. Cytopathological Study of the Circulating Tumor Cells filtered from the Cancer Patients’ Blood using Hydrogel-based Cell Block Formation

135. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer

136. Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy

137. Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience

138. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis

139. PD29-02 IMPACTS OF AGE AND COMORBIDITY ON SURVIVAL VARIES BY RISK GROUP IN PATIENTS WITH PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY: A COMPETING RISK ANALYSIS FROM K-CAP REGISTRY

140. PD10-01 DOES CURCUMIN PLAY A ROLE IN PROSTATE CANCER SUPPRESSION?: A RANDOMIZED, DOUBLE-BLIND

141. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy

142. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma

143. Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy

144. Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

145. Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6

146. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy

147. Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma

148. Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance

149. Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma

150. A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer

Catalog

Books, media, physical & digital resources